Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
13%(1 trials)

Phase Distribution

Ph not_applicable
11
92%
Ph phase_1
1
8%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
N/ANon-phased studies
11(91.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(8)
Terminated(1)
Other(3)

Detailed Status

Completed8
unknown3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (8.3%)
N/A11 (91.7%)

Trials by Status

completed867%
unknown325%
withdrawn18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
PROCEDURE
Total Trials
12